Fresh analysis reveals that individuals who stop using new GLP-1 drugs like Mounjaro or Wegovy may regain lost weight far faster than those who halt conventional diet and exercise plans.
Findings released in a prominent medical journal demonstrates that while obese people frequently drop substantial amounts of their body weight while using the jabs, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals buying these treatments need to be aware of the potential of rapid rebound weight gain when the medication ends," cautioned expert Dr. Susan Jebb.
That rate of recovery implies a reversion to pre-treatment mass within about one and a half years.
Comparing Approaches
The research, which reviewed 37 of trials involving over 9,000 of participants, compared the results of GLP-1 agonists with older methods.
The team emphasize that individuals who shed pounds through diet and exercise generally have a more gradual weight regain—around 0.1 kg a month—after stopping.
The Reason for the Fast Rebound
Nutrition scientists believe the way of the jabs explains the heightened weight return.
The injections copy a body's own chemical called GLP-1, which controls feelings of fullness.
"Long-term administration of the hormone concentrations several times higher than the body's typical production might result in the body to generate a reduced amount of its own natural hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this GLP-1 'fix' means hunger is no longer kept in check, making binge eating much more probable."
A Chronic Condition?
The NHS recommend the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.
A number of clinicians contend that, given the likelihood of weight regain, the therapy is often life-long.
This perspective is reinforced by pharmaceutical companies, who state that the findings "highlight the long-term character of obesity," akin to managing conditions like diabetes.
User Testimonies
Users who have come off the jabs describe a powerful return of hunger.
"It felt as if something flipping and I was suddenly starving," recalled one woman.
The struggle is worsened if patients have not adopted permanent lifestyle or habit modifications during therapy.
Growing Interest
Recent estimates show that a significant number of adults in the UK have tried weight-loss jabs in the past year, with interest being substantial.
- Use is more common among females compared to males.
- The 40s and 50s age group shows the greatest usage rates.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, researchers stress that while these medications are potent agents for shedding pounds, they are not a standalone solution and long-term success hinges on integrated lifestyle changes.
